Wedbush raises Adicet Bio target price to $28 from $25
ACET•Wedbush raised its target price for Adicet Bio to $28 from $25.
Related News
CPI renews multi-year service agreement with Vericast
PMTS•
Imunon converts $1.2 million debt into newly issued preferred shares
IMNN•
Rockland Trust finances Pennrose Lenox housing project with $22 million package
INDB•
Tokyo Lifestyle converts JPY 510 million shareholder loan into equity
TKLF•
SaverOne wins new U.S. patent for automated sensor fusion calibration maintenance
SVRE•